Adidas AG (ADS GR): Profitable Growth rank of 10 was down compared to the prior period’s 8th rank. This is poor performance compared to 950 large Cons. Disc. companies worldwide.
Read MoreIn this episode, Bill Bellows and host Andrew Stotz discuss seeing organizations as holograms—3D images. Holograms show all parts from different views at once. Learn how using the lens of the System of Profound Knowledge lets you see the problems and opportunities for transformation.
Read MoreJohnson & Johnson (JNJ US): Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank. This is World Class performance compared to 380 large Health Care companies worldwide.
Read MoreSinovac Biotech Limited (SVA US): Profitable Growth rank of 8 was same compared to the prior period’s 8th rank. This is below average performance compared to 400 medium Health Care companies worldwide.
Read MorePfizer Incorporated (PFE US): Profitable Growth rank of 5 was down compared to the prior period’s 1st rank. This is average performance compared to 380 large Health Care companies worldwide.
Read MoreAstraZeneca PLC (AZN LN): Profitable Growth rank of 4 was down compared to the prior period’s 3rd rank. This is above average performance compared to 380 large Health Care companies worldwide.
Read MoreDo you struggle to meet your goals or targets? Find out how you can change your thinking about goals and your process for setting them so you can keep moving forward. In this episode, John Dues and host Andrew Stotz discuss the first five of John’s 10 Key Lessons for Data Analysis.
Read MoreSinopharm Group Company Limited (1099 HK): Profitable Growth rank of 8 was same compared to the prior period’s 8th rank. This is below average performance compared to 380 large Health Care companies worldwide.
Read More